Delivery Order SPE2DR25D2206-SPE2DR26F9KM4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,107.32 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on January 6, 2026, with completion scheduled for January 7, 2026. This firm fixed-price delivery order represents a non-set-aside procurement issued under full and open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a ceiling value of $3,814.44. The delivery order is set to be completed by December 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award reflects competitive procurement practices and demonstrates AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,905.66 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of May 13, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,255.74 for Carvedilol ER 20 mg capsules (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.03 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count packaging) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for carvedilol ER 20 mg capsules (30-count units) valued at $2,258.53 with a firm fixed price and an ultimate completion date of April 10, 2025. This non-set-aside, competitively awarded contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,958.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). The contract represents a non-competitive delivery order with an ultimate completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.82 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a $35,680.03 delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on September 22, 2025, with a completion deadline of September 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9KM4Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,111.50 for Carvedilol ER 40 mg capsules (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This delivery order represents a routine pharmaceutical supply requirement supporting military healthcare programs through the broader pharmaceutical supply vehicle held by Cencora, Inc. The Carvedilol ER medication is a beta-blocker used for cardiovascular disease management and is typical of the diverse range of prescription medications and medical supplies that AmerisourceBergen provides to the Department of Defense and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements across multiple therapeutic domains, including specialty medications, generic drugs, and critical medical supplies needed by military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 1/8/26 |